A Syngeneic ErbB2 Mammary Cancer Model for Preclinical Immunotherapy Trials

MLA

Matthew T. Silvestrini, et al. “A Syngeneic ErbB2 Mammary Cancer Model for Preclinical Immunotherapy Trials.” Journal of Mammary Gland Biology and Neoplasia, vol. 24, Feb. 2019, pp. 149–62. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....9451193b04b765c80b2caa84ba4c77de&authtype=sso&custid=ns315887.

APA

Matthew T. Silvestrini, Clifford G. Tepper, Alexander D. Borowsky, Zsófia Pénzváltó, Jane Qian Chen, Ryan R. Davis, Maxine Umeh-Garcia, & Colleen A Sweeney. (2019). A Syngeneic ErbB2 Mammary Cancer Model for Preclinical Immunotherapy Trials. Journal of Mammary Gland Biology and Neoplasia, 24, 149–162.

Chicago

Matthew T. Silvestrini, Clifford G. Tepper, Alexander D. Borowsky, Zsófia Pénzváltó, Jane Qian Chen, Ryan R. Davis, Maxine Umeh-Garcia, and Colleen A Sweeney. 2019. “A Syngeneic ErbB2 Mammary Cancer Model for Preclinical Immunotherapy Trials.” Journal of Mammary Gland Biology and Neoplasia 24 (February): 149–62. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....9451193b04b765c80b2caa84ba4c77de&authtype=sso&custid=ns315887.